Wu, S., Xiang, R., Zhong, Y., Zhao, S., Zhang, Z., Kou, Z., . . . Wang, B. TLR7/8/9 agonists and low-dose cisplatin synergistically promotes tertiary lymphatic structure formation and antitumor immunity. Nature Portfolio.
Chicago Style (17th ed.) CitationWu, Shuting, et al. TLR7/8/9 Agonists and Low-dose Cisplatin Synergistically Promotes Tertiary Lymphatic Structure Formation and Antitumor Immunity. Nature Portfolio.
MLA (9th ed.) CitationWu, Shuting, et al. TLR7/8/9 Agonists and Low-dose Cisplatin Synergistically Promotes Tertiary Lymphatic Structure Formation and Antitumor Immunity. Nature Portfolio.
Warning: These citations may not always be 100% accurate.